Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history now indicates a new software revision (v3.6.6) replacing the prior revision (v3.6.5), reflecting a behind-the-scenes release update rather than a change to study content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe footer now shows the revised system version from v3.6.4 to v3.6.5, indicating a backend/UI update. This change does not modify the study history entries or any trial data displayed on the page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe revision tag at the bottom of the page updated from v3.6.3 to v3.6.4. This indicates a behind-the-scenes update to the ClinicalTrials.gov interface on the study history page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now lists Revision: v3.6.3 as the latest version, superseding v3.6.2. This signifies a minor administrative update to the historical record rather than changes to study content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe revision label on the history page updated from v3.6.0 to v3.6.2, indicating a small update to the page’s version; it reflects an internal update rather than changes to the study information.SummaryDifference0.1%

- Check91 days agoChange DetectedThe history now notes that recruitment is closed and records a new revision (v3.6.0). The previous revision label (v3.5.5) has been removed.SummaryDifference0.3%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.